Skip to main content
Market intelligence
HUMAHealthcare

Humacyte Inc insider activity

In the last 90 days, 2 corporate insiders purchased $59,839 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$59,839
Corporate buyers
2
Latest transaction
May 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 19, 2026Kathleen SebeliusDirectorOpen Market Purchase56,818$0.88$50,000
May 18, 2026Shamik J ParikhChief Medical OfficerSale45,887$0.90$41,147
May 18, 2026Dale A. SanderCFO and Chief Corp. Dev. OffSale45,887$0.90$41,147